These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6593774)

  • 1. In vitro assessment of drug sensitivity in acute nonlymphocytic leukemia.
    Preisler HD; Raza A
    Recent Results Cancer Res; 1984; 94():102-15. PubMed ID: 6593774
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay.
    Preisler HD; Azarnia N
    Br J Haematol; 1984 Dec; 58(4):633-40. PubMed ID: 6518136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of the CFU-C assay in acute nonlymphocytic leukemia.
    Kirshner JJ; Goldberg J; Nelson DA; Gottlieb AJ
    Am J Med; 1982 Apr; 72(4):615-19. PubMed ID: 7041644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term in vitro sensitivity testing in acute leukemia.
    Schwarzmeier JD; Pirker R; Paietta E
    Recent Results Cancer Res; 1984; 94():116-26. PubMed ID: 6593775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the human tumor colony forming assay for new drug development.
    Issell BF; Catino JJ; Bradley EC
    Recent Results Cancer Res; 1984; 94():237-44. PubMed ID: 6494584
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive drug testing on human tumor cells.
    Recent Results Cancer Res; 1984; 94():1-285. PubMed ID: 6494572
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental approaches to drug testing and clonogenic growth: results in multiple myeloma and acute myelogenous leukemia.
    Durie BG
    Recent Results Cancer Res; 1984; 94():93-101. PubMed ID: 6593779
    [No Abstract]   [Full Text] [Related]  

  • 9. Leukemic colony (L-CFU) formation in vitro: clinical correlations of the in vitro growth pattern of L-CFU and drug sensitivity in acute leukemia.
    Moriyama Y; Sanada M
    Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1583-8. PubMed ID: 6675406
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia.
    Raza A; Maheshwari Y; Mandava N; Yasin Z; Perveen S; Mayers G; Browman G; Goldberg J; Gottlieb A; Grunwald H
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):217-25. PubMed ID: 3589695
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of secondary acute nonlymphocytic leukemia.
    Beltran G; Stuckey WJ
    N Engl J Med; 1983 May; 308(21):1295-6. PubMed ID: 6573569
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
    Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW
    Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro test for studying sensitivity to Ara-C in leukemic patients].
    Onetto N; Momparler RL; Momparler LF; Gyger M; Rivard GE
    Union Med Can; 1987 Feb; 116(2):114-6. PubMed ID: 3564185
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug combination testing with in vitro clonal cultures.
    Aapro MS
    Recent Results Cancer Res; 1984; 94():224-31. PubMed ID: 6494583
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of schedule dependency of anticancer drugs in the human tumor clonogenic assay.
    Ludwig R; Alberts DS; Salmon SE
    Recent Results Cancer Res; 1984; 94():202-4. PubMed ID: 6494581
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity and variability of test results as limiting factors for predictive assays.
    Schlag P; Flentje D
    Recent Results Cancer Res; 1984; 94():191-6. PubMed ID: 6494579
    [No Abstract]   [Full Text] [Related]  

  • 17. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interlaboratory comparison of in vitro cloning of fresh human tumor cells from malignant effusions.
    Hofmann V; Holdener EE; Müller M; Früh U
    Recent Results Cancer Res; 1984; 94():197-201. PubMed ID: 6494580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Symposium on treatment of cancer. Supplement 2. Differential sensitivities of long-term cultured cell lines derived from human haematopoietic malignancies to various anti-cancer drugs].
    Morikawa K; Note S
    Nihon Naika Gakkai Zasshi; 1984 Nov; 73(11):1625-7. PubMed ID: 6520521
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive value of in vitro colony and cluster formation in acute nonlymphocytic leukemia.
    Goldberg J; Tice D; Nelson DA; Gottlieb AJ
    Am J Med Sci; 1979; 277(1):81-4. PubMed ID: 426001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.